Rachel focuses her practice on health care industry transactions.
Prior to joining Mintz, Rachel was a health care associate in the Washington, DC office of an Am Law 200 law firm, where she represented long-term care clients in complex multistate transactions; helped health systems structure financial arrangements with referral sources; advised pharmaceutical manufacturers and pharmacy benefit managers on state laws affecting drug pricing transparency; and counseled clients on compliance with the Anti-Kickback Statute, Stark Law, False Claims Act, Medicare billing and reimbursement regulations, beneficiary inducement prohibitions, civil monetary penalties, and the Health Insurance Portability and Accountability Act (HIPAA). Rachel also represented providers under investigation by the Department of Justice (DOJ), assisted providers with designing and implementing effective compliance programs, and provided representation in significant reimbursement and coverage disputes.
Earlier Rachel was a compliance attorney with Sentara Healthcare, a health care system with 12 acute care hospitals and more than 300 sites of care in Virginia and North Carolina. Focusing on the physician contracting process, Rachel developed strategic solutions to operational problems and provided legal support for compliance issues across the system.
Rachel also worked as a legal fellow at Bon Secours Richmond Health System, where she focused on risk management and regulatory compliance.
An active member of the American Bar Association’s Health Law Section, Rachel assisted in drafting several revisions to the group’s reference guide, Health Care Fraud and Abuse: Practical Perspectives, and organized and moderated a panel of senior government attorneys for an ABA networking event. She is frequently invited to speak on health care compliance and other health law matters.
More Legal and Business Bylines From Rachel E. Yount
- OIG Reiterates its Longstanding Concern about Joint Ventures between Health Care Providers/Suppliers and Referral Sources - (Posted On Wednesday, December 01, 2021)
- OIG Revises and Renames the Provider Self-Disclosure Protocol - (Posted On Wednesday, November 10, 2021)
- OIG Issues Favorable Advisory Opinion on Hospital’s Warranty Program for Joint Replacement Procedures - (Posted On Monday, September 20, 2021)
- PhRMA Updates its Code on Interactions with Health Care Professionals in Response to the OIG's Special Fraud Alert on Speaker Programs - (Posted On Tuesday, August 17, 2021)
- Combatting Patient Leakage by Directing Physician Referrals: What is Permitted under the Stark Law? - (Posted On Thursday, July 29, 2021)
- Pharmaceutical and Medical Device Manufacturers Be Advised: Sunshine Act / Open Payments Enforcement is on the Rise - (Posted On Thursday, May 27, 2021)
- Health Law Diagnosed — Final Rules Amending the Anti-Kickback Statute and Stark Law Regulations: Part 2 [PODCAST] - (Posted On Wednesday, March 17, 2021)
- Final Rules Amending the Anti-Kickback Statute and Stark Law Regulations: Part 1 [PODCAST] - (Posted On Tuesday, February 16, 2021)
- HHS Finalizes Highly Anticipated Final Rule Amending Anti-Kickback Statute and Stark Law Regulations, Part VI: Changes to Fundamental Stark Law Terminology - (Posted On Monday, February 08, 2021)
- HHS Finalizes Highly Anticipated Final Rule Amending Anti-Kickback Statute and Stark Law Regulations, Part V: Cybersecurity Technology and Electronic Health Records - (Posted On Friday, February 05, 2021)